Ken Harada
Nagoya University
38 Papers
230 Citations
Ken Harada is an academic researcher from Nagoya University. The author has contributed to research in topics: Medicine & Coronary artery disease. The author has an hindex of 15, co-authored 32 publications.
Chat about Author
Papers
Impact of omega-3 polyunsaturated fatty acids on coronary plaque instability: an integrated backscatter intravascular ultrasound study.
Tetsuya Amano,Tatsuaki Matsubara,Tadayuki Uetani,Masataka Kato,Bunichi Kato,Tomohiro Yoshida,Ken Harada,Soichiro Kumagai,Ayako Kunimura,Yusaku Shinbo,Katsuhide Kitagawa,Hideki Ishii,Toyoaki Murohara +12 more
TL;DR: A lower serum content of ω3 PUFAs was significantly associated with lipid-rich plaques, suggesting the contribution to the incidence of acute coronary syndrome.
89
Cardiac 64-multislice computed tomography reveals increased epicardial fat volume in patients with acute coronary syndrome.
Ken Harada,Tetsuya Amano,Tadayuki Uetani,Yoshiyuki Tokuda,Katsuhide Kitagawa,Yusaku Shimbo,Ayako Kunimura,Soichiro Kumagai,Tomohiro Yoshida,Bunichi Kato,Masataka Kato,Nobuyuki Marui,Hideki Ishii,Tatsuaki Matsubara,Toyoaki Murohara +14 more
TL;DR: A large amount of epicardial fat may be a risk factor for ACS, and EFV was larger in patients with ACS than in the control group, demonstrating significantly increased EFV.
69
Lipid-rich plaques predict non-target-lesion ischemic events in patients undergoing percutaneous coronary intervention.
Tetsuya Amano,Tatsuaki Matsubara,Tadayuki Uetani,Masataka Kato,Bunichi Kato,Tomohiro Yoshida,Ken Harada,Soichiro Kumagai,Ayako Kunimura,Yusaku Shinbo,Hideki Ishii,Toyoaki Murohara +11 more
TL;DR: LRP measured using IB-IVUS proved to be an independent morphologic predictor of non-target ischemic events after PCI, particularly enhancing the risk in patients with elevated serum CRP levels.
46
Impact of periprocedural anticoagulation therapy on the incidence of silent stroke after atrial fibrillation ablation in patients receiving direct oral anticoagulants: uninterrupted vs. interrupted by one dose strategy.
Tomoyuki Nagao,Hitomi Suzuki,Syun Matsunaga,Yoshinori Nishikawa,Kazuhiro Harada,Kumiko Mamiya,Norihiro Shinoda,Ken Harada,Masataka Kato,Nobuyuki Marui,Tetsuya Amano,Yasuya Inden,Toyoaki Murohara +12 more
TL;DR: Investigating the feasibility of uninterrupted DOAC strategy by evaluating the incidence of silent stroke (SS) and perioperative trends in coagulation markers compared with the interrupted strategy found Silent stroke incidence in the IG was significantly higher than that in the UG; this seems to be supported by the difference in PF1 + 2 values between the Ug and IG.
37
Beneficial effects of torasemide on systolic wall stress and sympathetic nervous activity in asymptomatic or mildly symptomatic patients with heart failure: comparison with azosemide.
Ken Harada,Hideo Izawa,Takao Nishizawa,Akihiro Hirashiki,Yosuke Murase,Masakazu Kobayashi,Satoshi Isobe,Xian Wu Cheng,Akiko Noda,Kohzo Nagata,Mitsuhiro Yokota,Toyoaki Murohara +11 more
TL;DR: It is indicated that torasemide treatment reduced LV systolic wall stress without activation of the sympathetic nervous system in patients with CHF, and the anti-aldosteronergic properties of torAsemide may contribute to its favorable effects.
28